annual ROE:
-27.85%-5.73%(-25.90%)Summary
- As of today (September 10, 2025), XENE annual return on equity is -27.85%, with the most recent change of -5.73% (-25.90%) on December 31, 2024.
- During the last 3 years, XENE annual ROE has fallen by -5.98% (-27.34%).
- XENE annual ROE is now -203.65% below its all-time high of 26.87%, reached on December 31, 2014.
Performance
XENE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-37.25%-5.73%(-18.18%)Summary
- As of today (September 10, 2025), XENE quarterly return on equity is -37.25%, with the most recent change of -5.73% (-18.18%) on June 1, 2025.
- Over the past year, XENE quarterly ROE has dropped by -12.01% (-47.58%).
- XENE quarterly ROE is now -174.80% below its all-time high of 49.80%, reached on September 30, 2014.
Performance
XENE quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
XENE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.9% | -47.6% |
| 3 y3 years | -27.3% | -93.4% |
| 5 y5 years | +34.6% | -67.3% |
XENE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.2% | at low | -99.2% | at low |
| 5 y | 5-year | -41.2% | +34.6% | -112.5% | at low |
| alltime | all time | -203.7% | +54.7% | -174.8% | +43.1% |
XENE ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -37.25%(+18.2%) |
| Mar 2025 | - | -31.52%(+13.3%) |
| Dec 2024 | -27.85%(+25.9%) | -27.81%(+6.7%) |
| Sep 2024 | - | -26.06%(+3.2%) |
| Jun 2024 | - | -25.24%(+1.3%) |
| Mar 2024 | - | -24.91%(-1.2%) |
| Dec 2023 | -22.12%(+12.2%) | -25.20%(-0.8%) |
| Sep 2023 | - | -25.41%(+11.5%) |
| Jun 2023 | - | -22.78%(+7.8%) |
| Mar 2023 | - | -21.13%(+13.0%) |
| Dec 2022 | -19.72%(-9.8%) | -18.70%(-5.1%) |
| Sep 2022 | - | -19.71%(+2.3%) |
| Jun 2022 | - | -19.26%(-12.8%) |
| Mar 2022 | - | -22.09%(-15.8%) |
| Dec 2021 | -21.87%(-0.1%) | -26.23%(-9.2%) |
| Sep 2021 | - | -28.90%(+5.3%) |
| Jun 2021 | - | -27.44%(+48.9%) |
| Mar 2021 | - | -18.43%(+5.1%) |
| Dec 2020 | -21.90%(-48.6%) | -17.53%(-8.7%) |
| Sep 2020 | - | -19.21%(-13.7%) |
| Jun 2020 | - | -22.27%(-37.5%) |
| Mar 2020 | - | -35.63%(-23.8%) |
| Dec 2019 | -42.60% | -46.74%(+11.9%) |
| Sep 2019 | - | -41.78%(-17.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | -50.31%(-7.7%) |
| Mar 2019 | - | -54.53%(+4.2%) |
| Dec 2018 | -49.55%(-19.4%) | -52.35%(-17.0%) |
| Sep 2018 | - | -63.08%(-3.7%) |
| Jun 2018 | - | -65.52%(+4.7%) |
| Mar 2018 | - | -62.55%(+2.2%) |
| Dec 2017 | -61.51%(+67.1%) | -61.22%(+21.5%) |
| Sep 2017 | - | -50.40%(+3.4%) |
| Jun 2017 | - | -48.75%(+7.8%) |
| Mar 2017 | - | -45.23%(+20.0%) |
| Dec 2016 | -36.81%(+56.4%) | -37.69%(+10.1%) |
| Sep 2016 | - | -34.24%(+20.8%) |
| Jun 2016 | - | -28.34%(+82.3%) |
| Mar 2016 | - | -15.55%(-4.7%) |
| Dec 2015 | -23.54%(-187.6%) | -16.32%(-492.3%) |
| Sep 2015 | - | 4.16%(-77.6%) |
| Jun 2015 | - | 18.57%(+240.1%) |
| Mar 2015 | - | 5.46%(-83.3%) |
| Dec 2014 | 26.87%(+28.7%) | 32.75%(-34.2%) |
| Sep 2014 | - | 49.80%(+11.0%) |
| Jun 2014 | - | 44.88%(+5.4%) |
| Mar 2014 | - | 42.57%(+15.5%) |
| Dec 2013 | 20.87%(-161.3%) | 36.87% |
| Dec 2012 | -34.07% | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual return on equity?
- What is the all time high annual ROE for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual ROE year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly ROE year-on-year change?
What is Xenon Pharmaceuticals Inc. annual return on equity?
The current annual ROE of XENE is -27.85%
What is the all time high annual ROE for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual return on equity is 26.87%
What is Xenon Pharmaceuticals Inc. annual ROE year-on-year change?
Over the past year, XENE annual return on equity has changed by -5.73% (-25.90%)
What is Xenon Pharmaceuticals Inc. quarterly return on equity?
The current quarterly ROE of XENE is -37.25%
What is the all time high quarterly ROE for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly return on equity is 49.80%
What is Xenon Pharmaceuticals Inc. quarterly ROE year-on-year change?
Over the past year, XENE quarterly return on equity has changed by -12.01% (-47.58%)